Back
Results - Announcements
Sales decline 15.82% to Rs 55.83 crore
Beta Drugs standalone net profit rises 40.19% in the June 2026 quarter
20-Jul-2026, 12:19
Net profit of Beta Drugs rose 40.19% to Rs 5.93 crore in the quarter ended June 2026 as against Rs 4.23 crore during the previous quarter ended June 2025. Sales declined 15.82% to Rs 55.83 crore in the quarter ended June 2026 as against Rs 66.32 crore during the previous quarter ended June 2025.
Net profit of Beta Drugs rose 40.19% to Rs 5.93 crore in the quarter ended June 2026 as against Rs 4.23 crore during the previous quarter ended June 2025. Sales declined 15.82% to Rs 55.83 crore in the quarter ended June 2026 as against Rs 66.32 crore during the previous quarter ended June 2025.
| Particulars | Quarter Ended | ||
| Jun. 2026 | Jun. 2025 | % Var. | |
| Sales | 55.83 | 66.32 | -16 |
| OPM % | 18.18 | 11.32 | - |
| PBDT | 10.42 | 7.69 | 36 |
| PBT | 7.93 | 5.65 | 40 |
| NP | 5.93 | 4.23 | 40 |
Powered by Capital Market - Live News